uniQure

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell uniQure and other ETFs, options, and stocks.

About QURE

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems.

CEO

Matthew C. Kapusta

CEOMatthew C. Kapusta

Employees

209

Employees209

Headquarters

Amsterdam, Noord-Holland

HeadquartersAmsterdam, Noord-Holland

Founded

2012

Founded2012

Employees

209

Employees209

QURE Key Statistics

Market cap

772.25M

Market cap772.25M

Price-Earnings ratio

-3.31

Price-Earnings ratio-3.31

Dividend yield

—

Dividend yield—

Average volume

879.25K

Average volume879.25K

High today

$14.73

High today$14.73

Low today

$13.80

Low today$13.80

Open price

$14.60

Open price$14.60

Volume

868.34K

Volume868.34K

52 Week high

$19.18

52 Week high$19.18

52 Week low

$4.45

52 Week low$4.45

Analyst ratings

86%

of 14 ratings

Buy

85.7%

Hold

14.3%

Sell

People also own

Based on the portfolios of people who own QURE. This list is generated using Robinhood data, and it’s not a recommendation.